Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Outlook for the Future|Hans Tung,Managing Partner,GGV Capital
00:10:00
Exploring Post-Liberalism: Insights from Professor Gary Houchens|Gary Houchens,Professor,Western Kentucky University
00:10:00
catalyze the biopharma industry not just in the LA region but beyond|Beth Seidenberg,Managing Director,Westlake Village Biopartners
00:10:00
Green Energy Strategy Unveiled: Ignito's Group Aims for 100% Renewable Power in Europe by 2050| Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Is Higher Inflation on the Horizon? Insights from Max Monk and Ryan Martin of Johnson Investment Counsel
00:10:00
King Cora Copper's Exploration Ambitions in Mongolia: Insights from CEO Sam Spring at the One-to-One Conference
00:10:00
Technology's Role in Addressing Global Threats|Carey Smith, CEO, Parsons Corporation.
00:10:00
Insight on how to disrupt an industry with signs of product-market |Pieter Abbeel,Investment Partner,AIX Ventures
00:10:00
Jim Russo on Peloton, USMCA, the Fed, and U.S.-China Trade Tensions | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Navigating Career Pathways: Insights from a Neuroscientist Turned Oncology CEO| Mark Erlander, CEO, Cardiff Oncology Inc.
00:10:00
George Glazier Discusses Western Uranium and Vanadium’s OTCQX Best 50 Recognition and Market Outlook
00:10:00
South African Diamond Mining Firm Explores Near-Term Production Opportunities at One-to-One Mining Conference

© 2017 - Neuhu+